-
1
-
-
33747362870
-
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
-
Li J, Nation RL, Turnidge JD et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006; 6: 589-601.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 589-601
-
-
Li, J.1
Nation, R.L.2
Turnidge, J.D.3
-
2
-
-
60649100857
-
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
-
Aoki N, Tateda K, Kikuchi Y et al. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2009; 63: 534-42.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 534-542
-
-
Aoki, N.1
Tateda, K.2
Kikuchi, Y.3
-
3
-
-
27644585168
-
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
-
Li J, Rayner CR, Nation RL et al. Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 2005; 49: 4814-5.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 4814-4815
-
-
Li, J.1
Rayner, C.R.2
Nation, R.L.3
-
4
-
-
38649127867
-
Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS
-
Ma Z, Wang J, Gerber JP et al. Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 862: 205-12.
-
(2008)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.862
, pp. 205-212
-
-
Ma, Z.1
Wang, J.2
Gerber, J.P.3
-
5
-
-
67749145541
-
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram negative bacteria
-
Plachouras D, Karvanen M, Friberg LE et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram negative bacteria. Antimicrob Agents Chemother 2009; 53:3430-6.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3430-3436
-
-
Plachouras, D.1
Karvanen, M.2
Friberg, L.E.3
-
6
-
-
0037378043
-
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography
-
Li J, Milne RW, Nation RL et al. Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography. Antimicrob Agents Chemother 2003; 47: 1364-70.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 1364-1370
-
-
Li, J.1
Milne, R.W.2
Nation, R.L.3
-
7
-
-
50949124169
-
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients
-
Wallace SJ, Li J, Rayner CR et al. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother 2008; 52: 3047-51.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3047-3051
-
-
Wallace, S.J.1
Li, J.2
Rayner, C.R.3
-
8
-
-
0348149151
-
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
-
Li J, Coulthard K, Milne R et al. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J Antimicrob Chemother 2003; 52: 987-92.
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 987-992
-
-
Li, J.1
Coulthard, K.2
Milne, R.3
-
9
-
-
77954188189
-
Optimizing and preserving the activity of colistin
-
American Society for Microbiology, Washington, DC, USA
-
Li J. Optimizing and preserving the activity of colistin. In: Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2009. Abstract 1205, p. 82. American Society for Microbiology, Washington, DC, USA.
-
(2009)
Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA
, pp. 82
-
-
Li, J.1
-
10
-
-
54549084625
-
Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma
-
Cao G, Ali FEA, Chiu F et al. Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma. J Antimicrob Chemother 2008; 62: 1009-14.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 1009-1014
-
-
Cao, G.1
Ali, F.E.A.2
Chiu, F.3
|